Human KRAS (2-185,G12C) Protein, His Tag (active enzyme)
ACROBiosystemsHuman KRAS (2-185,G12C), His Tag (KRS-H51H3) is expressed from E.coli cells.
Human KRAS (2-185,G12C), His Tag (KRS-H51H3) is expressed from E.coli cells.
resDetect™ DNase Activity Assay Kit (Fluorescence) uses the FRET method to detect DNase in buffers, reagents, and other components within 30 minutes. It offers a rapid, sensitive, and quantitative tool for identifying DNase contamination. Additionally, the DNase and RNase Activity Assay Kit enables simultaneous quantitative detection of DNases and RNases in a single assay.
resDetect™ T7 RNA Polymerase ELISA Kit uses the ELISA sandwich method to detect and quantify T7 RNA Polymerase residues in mRNA drugs. It includes T7 RNA Polymerase (ACROBiosystems, cat# T7E-E5143) for accuracy and ensures reliable monitoring during mRNA production. The kit also serves as a universal tool for T7 RNA Polymerase quantification.
resDetect™ RNase Activity Assay Kit (Fluorescence) uses the FRET method to detect RNase in buffers, reagents, and other components within 30 minutes. It offers a rapid, sensitive, and quantitative tool for identifying RNase contamination. Additionally, the DNase and RNase Activity Assay Kit enables simultaneous quantitative detection of DNases and RNases in a single sample.
resDetect™ Cas9 ELISA Kit uses the Sandwich-ELISA method for quantitative detection of Cas9 residues in cell therapy products. It supports quality control in gene and cell therapy manufacturing by monitoring Cas9 residues during in-process testing and final product release, ensuring safety and compliance in CRISPR-based therapies.
ACRO has developed a full range of full-length multi-pass transmembrane proteins with stabilized structure and high activity including CD20, Claudin18.2, CD133, GPRC5D, CXCR4, CCR5 and CCR8.
ACROBiosystems offers a comprehensive collection of recombinant Fc receptor proteins including FcRn FcγRs, FcεRs to expedite antibody drug development and research programs.
PE-Labeled anti FMC63 antibody can specifically recognize the antigen-recognition domain of FMC63 derived CARs with high bioactivity, and this antibody can be used for detecting anti-CD19 (FMC63 scFv) CAR expression by Flow Cytometry.
The exclusive specific antibody can only bind to Omicron Spike RBD and not bind to other SARS-CoV-2 strains. with high bioactivity and purity, the antibody can be used for mutant antigen quantitative detection requirement during the process of polyvalent and Omicron-based vaccine R&D.
ACROBiosystems has developed a full range of immune checkpoint proteins, including co-inhibitory receptors, co-stimulatory receptors, inhibitor screening kits, and others.
Monoclonal Anti-Claudin-18.2 Antibody, Mouse IgG1 (3B10) was developed to be exquisitely CLDN18.2 specific, characterized as not cross-reacting with CLDN18.1 and without background staining.